Health Care/Hospital
INOVIO and QIAGEN expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO's VGX-3100 for advanced cervical dysplasia
- Liquid biopsy-based precision test guides patient selection and offers potential for cost-effective, non-invasive alternative to surgical removal of cervical lesions - QIAGEN's bioinformatic expertise raises predictive biomarker power in INOVIO's patient selection - First-in-class next genera...
2021-02-24 14:45
6742
Additional Positive Interim Results from Nanoform's Clinical Study
HELSINKI, Feb. 24, 2021 /PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, today announced further positive interim results from its ongoing clinical study. The fast absorption data implies that small is powerful® and might offer viable alternatives to com...
2021-02-24 14:33
1485
Alternative meat startup Next Meats Co., Ltd and microalgae biotech company euglena Co., launch "NEXT Euglena Yakiniku EX" containing microalgae
TOKYO, Feb. 12, 2021 /PRNewswire/ -- Next Meats Co., LTD, the controlling shareholder of Next Meats Holdings, Inc. ("OTC: NXMH") announced that they had signed a joint product development agreement witheuglena Co., a biotech company also fromJapan which specializes in cultivating Euglena and Chlo...
2021-02-24 12:45
6144
WuXi Diagnostics Secures US$150 Million Series B Financing to Accelerate Market Penetration in Global Diagnostics Sector
SHANGHAI, Feb. 23, 2021 /PRNewswire/ -- WuXi Diagnostic Investment (Cayman) Limited ("WuXi Diagnostics") announced that it has completedUS$150 million in series B funding, joined by new investors including Thermo Fisher Scientific Inc. ("Thermo Fisher"), Shiyu Capital ("SHIYU"), ABC International...
2021-02-24 08:00
2801
Antengene Announces NDA for ATG-010 (Selinexor) Granted Priority Review by China's NMPA
SHANGHAI and HONG KONG, Feb. 24, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and onco...
2021-02-24 08:00
4513
Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc.
TOKYO, Feb. 23, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543), a global leader in medical technology, has signed a definitive agreement to acquire all assets of Health Outcomes Sciences, Inc. (HOS). HOS specializes in predictive analytics and clinical decision support that enable healthcare...
2021-02-24 07:00
9027
US Court Grants MGI's Motion to Amend in Suit Against Illumina
SAN FRANCISCO, Feb. 24, 2021 /PRNewswire/ -- A judge in the U.S. District Court for the Northern District ofCalifornia has granted MGI's motion for leave to amend to add a new inequitable conduct defense of patent infringement lawsuit that Illumina filed against MGI inFebruary 2020 (Case No. 20-c...
2021-02-24 04:00
4165
New Research Highlights the Potential of Transforming Healthcare with Mobile EEG Brain Health Assessments
Recent publications in Frontiers of Neuroscience, Scientific Report and Neurophysiologie Clinique validate the use of Muse® as a mobile EEG device to measure brain health and performance at scale in real-world environments TORONTO, Feb. 24, 2021 /PRNewswire/ -- In a time with overburdened healthc...
2021-02-24 03:21
1817
GBB Completes USD$3.8M Convertible Note Financing Led by Alibaba Hong Kong Entrepreneurs Fund
HONG KONG, Feb. 23, 2021 /PRNewswire/ -- Great Bay Bio Holdings Limited (hereinafter referred to as "GBB") today announced it has completed aUSD$3.8M Convertible Note Financing. Alibaba Hong Kong Entrepreneurs Fund (hereinafter referred to as "AEF") led the investment round with participation fro...
2021-02-23 23:00
2453
Skybox Security Announces 2020 Partner Awards
Channel and distributor partners recognized for commitment to customer excellence and performance SAN JOSE, Calif., Feb. 23, 2021 /PRNewswire/ -- Skybox Security, a global leader in security posture management, today announced the winners of its 2020 Partner Awards. The inaugural award program r...
2021-02-23 22:05
2708
ScImage Lauded by Frost & Sullivan for Its Cloud-based Enterprise Imaging Platform, PICOM365
Its seamless integration across imaging programs and tools give physicians single-platform access to all the tools needed to view and interpret images and videos from anywhere SANTA CLARA, Calif., Feb. 23, 2021 /PRNewswire/ -- Based on its recent analysis of the North American cloud-based enterp...
2021-02-23 22:00
1814
Rheumatology Clinical Researcher Professor David Hunter Joins George Clinical Scientific Leadership
OVERLAND PARK, Kan., Feb. 23, 2021 /PRNewswire/ -- David Hunter, MBBS, PhD, a renowned clinical researcher and rheumatology expert based inAustralia, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research organization. Professor Hunter's researc...
2021-02-23 22:00
1697
Inovalon Lauded by Frost & Sullivan for Continuously Advancing Data-Driven Healthcare with Its Cloud-Based Inovalon ONE® Platform
Inovalon combines industry interconnectivity, large-scale, comprehensive data assets, and analytics with subject matter expertise to support clients strategically SANTA CLARA, Calif., Feb. 23, 2021 /PRNewswire/ -- Based on its recent analysis of the North American healthcare and life sciences an...
2021-02-23 21:00
5231
INOVIO Announces First Subject Dosed in Phase 1B Clinical Trial for its DNA Vaccine Against Lassa Fever, INO-4500, in West Africa
Phase 1B clinical trial is first study for Lassa fever conducted in Africa Goal is for vaccine to be available for emergency use as stockpile product following Phase 2 Progress on INO-4500 reflects INOVIO's focus on and continued commitment to the fight against infectious diseases Trial fully f...
2021-02-23 21:00
5633
Gracell Biotechnologies to Report Fourth Quarter and Fiscal 2020 Financial Results on Tuesday, March 9, 2021
SUZHOU and SHANGHAI, China, Feb. 23, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies, today announced that it plans to release ...
2021-02-23 21:00
8186
RedHill Biopharma Announces Planned Expansion of Opaganib Global Phase 2/3 COVID-19 Study to the U.S.
TEL AVIV, Israel and RALEIGH, NC, Feb. 23, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
2021-02-23 20:33
4700
Barco Applauded by Frost & Sullivan for its Continued Domination of the Wireless Content Sharing Market
Its successful ClickShare product line, wide footprint, and strong technology partnership have helped it maintain its competitive edge SANTA CLARA, Calif., Feb. 23, 2021 /PRNewswire/ -- Based on its recent analysis of the global stand-alone wireless content sharing market,Frost & Sullivan recogn...
2021-02-23 20:17
1555
For third year straight, Elekta named one of the world's most ethical companies by Ethisphere
STOCKHOLM, Feb. 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has again been recognized as one of theWorld's Most Ethical Companies® by the Ethisphere Institute, a global leader in defining and advancing the standards of ethical business practices. The honor is bestowed upo...
2021-02-23 20:02
3672
Kira Pharmaceuticals Expands Executive Leadership Team with Chief Business Officer, Chief Medical Officer and Chief Commercial Officer, China
CAMBRIDGE, Mass. and SUZHOU, China, Feb. 23, 2021 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced the addition of three seasoned pharmaceutical leaders,Kathy He, R...
2021-02-23 20:00
4204
New Progress in Study on Mechanism of Lianhua Qingwen Capsules for Treatment of COVID-19
SHIJIAZHUANG, China, Feb. 23, 2021 /PRNewswire/ -- Recently, Prof. Caisheng Wu and Prof.Yifeng Chai from the School of Pharmacy, Xiamen University have made new progress in the study of the pharmacologically active ingredients and mechanism of Lianhua Qingwen Capsules, developed and produced by Y...
2021-02-23 17:05
2936
Week's Top Stories
Most Reposted
ARKANCE to Launch BIMLOGIQ - A New AI-Powered Extension to Its AEC Tech Stack Offering
[Picked up by 293 media titles]
2025-12-11 09:07
Synvo AI and Sobat Bisnis Group (SBG) Forge Strategic Partnership to Bring Secure, Context-Aware Enterprise AI to Indonesia and Southeast Asia
[Picked up by 290 media titles]
2025-12-16 08:00
Colebrook Bosson Saunders Chooses India for First Executive Dialogue Exploring Future of Workspaces and Technology
[Picked up by 287 media titles]
2025-12-16 14:26
Who Are China's Top 100 Most International Privately-Owned Enterprises?
[Picked up by 268 media titles]
2025-12-15 16:55
AbbVie Ranked #15 in the Inaugural Fortune 100 Best Companies to Work For Southeast Asia 2025 List
[Picked up by 258 media titles]
2025-12-15 09:00
